Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Jia-Zhen Wu"'
Publikováno v:
Chinese Medicine and Culture, Vol 4, Iss 2, Pp 99-106 (2021)
Externí odkaz:
https://doaj.org/article/b596187dec9745a29d89dee8de85f113
Publikováno v:
Diagnostics, Vol 12, Iss 10, p 2269 (2022)
Coronary artery disease (CAD) is a global health issue. Lipid peroxidation produces various by-products that associate with CAD, such as 4-hydroxynonenal (HNE) and malondialdehyde (MDA). The autoantibodies against HNE and MDA-modified peptides may be
Externí odkaz:
https://doaj.org/article/5338075011154b3889e05ae2c0262821
Autor:
Jia-Zhen Wu, Mustafa Ardah, Caroline Haikal, Alexander Svanbergsson, Meike Diepenbroek, Nishant N. Vaikath, Wen Li, Zhan-You Wang, Tiago F. Outeiro, Omar M. El-Agnaf, Jia-Yi Li
Publikováno v:
Translational Neurodegeneration, Vol 8, Iss 1, Pp 1-15 (2019)
Abstract Background Progressive accumulation of α-synuclein is a key step in the pathological development of Parkinson’s disease. Impaired protein degradation and increased levels of α-synuclein may trigger a pathological aggregation in vitro and
Externí odkaz:
https://doaj.org/article/5804e97c94bb42328dfc122517329af0
Publikováno v:
European Journal of Inflammation, Vol 16 (2018)
β-patchoulene (β-PAE) is one of the essential tricyclic sesquiterpenes of patchouli oil while β-patchoulene epoxide (β-PAO) is the oxidative product of β-PAE which can only be found in the oil with long storage period. Our previous researches de
Externí odkaz:
https://doaj.org/article/28251b4d26db443aa672e63c8de90525
Autor:
Jia-Li Liang, Jia-Zhen Wu, Yu-Hong Liu, Zhen-Biao Zhang, Qi-Duan Wu, Han-Bin Chen, Yan-Feng Huang, Yao-Xing Dou, Jiang-Tao Zhou, Zi-Ren Su, Janis Ya-Xian Zhan
Publikováno v:
Mediators of Inflammation, Vol 2017 (2017)
According to the GC-MS analysis, compositional variation was observed between samples of patchouli oil, of which an unknown compound identified as patchoulene epoxide (PAO) was found only in the long-stored oil, whose biological activity still remain
Externí odkaz:
https://doaj.org/article/ee10d69033c74d37aff7f41216b94d73
Autor:
Jia-Zhen Wu, 吳家禎
95
Based on the worldwide articles referring to folding wheelchair, related patens published and kinds of wheelchairs on-shelf in the market, most of wheelchairs can only act frontally. However, the volume after frontal-folded is still space-occ
Based on the worldwide articles referring to folding wheelchair, related patens published and kinds of wheelchairs on-shelf in the market, most of wheelchairs can only act frontally. However, the volume after frontal-folded is still space-occ
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/u9hpb2
Autor:
Qing‐Xin Wang, Yi‐Bo Wang, Jiu‐Kai Sha, Hai Zhou, Jia‐Chuan Liu, Jia‐Zhen Wu, Zhen‐Jiang Tong, Jiao Cai, Zi‐Jun Chen, Chen‐Qian Zhang, Xin‐Rui Zheng, Jing‐Jing Wang, Xiao‐Long Wang, Xin Xue, Yan‐Cheng Yu, Ning Ding, Xue‐Jiao Leng, Wei‐Chen Dai, Shan‐Liang Sun, Liang Chang, Nian‐Guang Li, Zhi‐Hao Shi
Publikováno v:
Drug Development Research. 84:296-311
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6899df1c68e1c20799636d9816200ece
https://doi.org/10.1002/ddr.22032
https://doi.org/10.1002/ddr.22032
Autor:
Qing-Xin Wang, Yu-Hao Cao, Li-Jin Yang, Yi-Yuan Ma, Nan Li, Shi-Han Wu, Lu Chen, Jia-Zhen Wu, Zhen-Jiang Tong, Xiao-Long Wang, Xin Xue, Ning Ding, Xue-Jiao Leng, Liang Chang, Wei-Chen Dai, Yan-Cheng Yu, Shan-Liang Sun, Ye Yang, Nian-Guang Li, Zhi-Hao Shi
Publikováno v:
Future Medicinal Chemistry. 15:57-71
Aim: The clinical benefits of FLT3 inhibitors against acute myeloid leukemia (AML) have been limited by selectivity and resistance mutations. Thus, to identify FLT3 inhibitors possessing high selectivity and potency is of necessity. Methods & results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4e2c6feedaad9225b8c2e4b4b234b20
https://doi.org/10.4155/fmc-2022-0231
https://doi.org/10.4155/fmc-2022-0231
Autor:
Zhi-Hao Shi, Nian-Guang Li, Shan-Liang Sun, Shi-Han Wu, Li-Jin Yang, Yi-Yuan Ma, Yu-Hao Cao, Zhen-Jiang Tong, Jia-Zhen Wu, Yi-Bo Wang, Jiu-Kai Sha, Ning Ding, Qiao-Li Liang, Liang Chang, Xiao-Long Wang, Jin-Ao Duan, Yan-Cheng Yu, Wei-Chen Dai, Ke Xie, Xue-Jiao Leng, Xin Xue
Publikováno v:
Letters in Drug Design & Discovery. 20
Background: Acute myeloid leukemia (AML) is the most common type of blood cancer. Fms-like tyrosine kinase 3 (FLT3) is a member of the class III receptor tyrosine kinase family. Overexpression of FLT3 was found in 70-100% of patients with acute myelo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9250921b9447897024d7ae8b81f00588
https://doi.org/10.2174/1570180820666230519140242
https://doi.org/10.2174/1570180820666230519140242
Autor:
Qing-Xin Wang, Peng-Yu Zhang, Qing-Qing Li, Zhen-Jiang Tong, Jia-Zhen Wu, Shao-Peng Yu, Yan-Cheng Yu, Ning Ding, Xue-Jiao Leng, Liang Chang, Jin-Guo Xu, Shan-Liang Sun, Ye Yang, Nian-Guang Li, Zhi-Hao Shi
Publikováno v:
European Journal of Medicinal Chemistry. 257:115464
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b3395521cdc946dda76a9e40851db36
https://doi.org/10.1016/j.ejmech.2023.115464
https://doi.org/10.1016/j.ejmech.2023.115464